{"slideshow_credits": null, "snippet": "Horizon Pharma said it was willing to pay $33 a share for its smaller American rival, up from its previous offer of $29.25 a share.", "abstract": "DealBook Online; Irish drug maker Horizon Pharma increases unsolicited offer for Depomed to $33 per share, representing 60 percent premium over closing price.", "section_name": "Business Day", "print_page": "5", "document_type": "article", "byline": {"person": [{"firstname": "Chad", "role": "reported", "lastname": "BRAY", "rank": 1, "organization": ""}], "original": "By CHAD BRAY"}, "web_url": "http://www.nytimes.com/2015/07/22/business/dealbook/horizon-pharma-sweetens-bid-for-drug-maker-depomed.html", "lead_paragraph": "Horizon Pharma said it was willing to pay $33 a share for its smaller American rival, up from its previous offer of $29.25 a share.", "headline": {"main": "Drug Maker Depomed Skeptical of Horzon Pharma\u2019s Latest Bid", "print_headline": "Drug Maker Offer"}, "_id": "55ae38a038f0d84cf5633e5b", "word_count": "672", "multimedia": [], "pub_date": "2015-07-22T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"name": "organizations", "value": "Horizon Pharma Inc", "is_major": "Y", "rank": "1"}, {"name": "organizations", "value": "Depomed Inc", "is_major": "Y", "rank": "2"}, {"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "is_major": "N", "rank": "3"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "is_major": "N", "rank": "4"}], "blog": [], "subsection_name": "DealBook", "type_of_material": "News"}